To gain insights into the molecular mechanisms underlying differential susceptibility of BC cells to CD32-CR T cells and to identify relevant transcriptional signatures, publicly available RNA sequences (RNA-Seq) were interrogated. This evidence concerns the gene FCGR2A and breast cancer.